Back to the Top
The following message was posted to: PharmPK
Dear all,
I would like to have advice about dissolution specifications established
with an IVIVC.
Can we simply evaluate a risk of being bioinequivalent with these
limits?
Is there any further correction to bring to these limits so that the
risk
of being bioinequivalent in vivo is reduced?
Thank you,
Aude Dunand
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (david@boomer.org)